Who Owns BioLineRx Stock?
NASDAQ: BLRXHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Ownership breakdown
- Held by institutions
- 1.34%
- Held by insiders
- 3.43%
- Institutional holders
- 14
- Institutions 1.3%
- Insiders 3.4%
- Public and other 95.2%
Who owns BioLineRx stock?
Institutional investors own about 1.3% of BioLineRx's shares, spread across 14 institutions that file 13F reports. That level of institutional ownership is relatively low, leaving more of the stock with retail investors and insiders. Insiders, including executives, directors and large founding shareholders, hold 3.43% of BLRX.
The largest institutional holders are Susquehanna International Group, LLP (0.62%), Renaissance Technologies, LLC (0.31%) and Citadel Advisors Llc (0.30%). Together, the top 10 institutions control 1.3% of shares outstanding. In their latest filings, 5 of the top 10 institutions increased their BLRX positions and 3 reduced them.
Summary generated from market data by MetaCap's automated system. Methodology
Top institutional holders of BLRX
| Institution | Shares | % Held | Change |
|---|---|---|---|
| Susquehanna International Group, LLP | 30.91K | 0.62% | +100.0% |
| Renaissance Technologies, LLC | 15.41K | 0.31% | +100.0% |
| Citadel Advisors Llc | 14.80K | 0.30% | +100.0% |
| Rhumbline Advisers | 2.48K | 0.05% | +5.3% |
| Wells Fargo & Company | 2.00K | 0.04% | +14.3% |
| BNP Paribas Financial Markets | 500 | 0.01% | -72.2% |
| Nemes Rush Group LLC | 250 | 0.01% | 0.0% |
| UBS Group AG | 101 | 0.00% | -80.9% |
| NewEdge Advisors, LLC | 82 | 0.00% | -23.4% |
| Osaic Holdings Inc. | 26 | 0.00% | 0.0% |
% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.
Top mutual fund and ETF holders of BLRX
| Fund | Shares | % Held |
|---|---|---|
| Fidelity Concord Street Trust-Fidelity Nasdaq Composite Index Fund | 999 | 0.03% |
Frequently asked questions
Who is the largest shareholder of BioLineRx?
Susquehanna International Group, LLP is the largest institutional shareholder of BLRX, owning 0.62% of shares outstanding (30.91K shares) as of its latest 13F filing.
What percentage of BioLineRx is owned by institutions?
Institutions own about 1.3% of BLRX shares and 1.4% of the public float.
How much of BioLineRx do insiders own?
Insiders, such as officers and directors, own about 3.43% of BLRX shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.